Thane Wettig insider trades

Open-market stock purchases and sales by Thane Wettig, CEO at Kyntra BIO, Inc, from SEC Form 4 filings since Jun 22, 2020.

Track record: 80% of 5 scored buys are up 5% or more since purchase, averaging +4%.

Recent trades

DateStockTradeValue
Sep 6, 2026KYNB Kyntra BIO, IncSold (not open market)$1.8K
Jun 6, 2026KYNB Kyntra BIO, IncSold (not open market)$1.3K
May 14, 2026KYNB Kyntra BIO, IncBought$19.9K
May 14, 2026KYNB Kyntra BIO, IncBought$19.9K
Mar 6, 2026KYNB Kyntra BIO, IncSold (not open market)$1.9K
Feb 3, 2026KYNB Kyntra BIO, IncBought (not open market)—
Dec 6, 2025FGEN Fibrogen IncSold (not open market)$2.2K
Nov 17, 2025FGEN Fibrogen IncBought$24.6K
Nov 13, 2025FGEN Fibrogen IncBought$9.2K

Companies traded

  • KYNB Kyntra BIO, Inc: 2 buys, last Sep 6, 2026
  • FGEN Fibrogen Inc: 5 buys, 11 sales, last Dec 6, 2025

Get free alerts when Thane Wettig files a new trade →